Search Results
Adding Pevonedistat to Azacitidine Shows Promise in MDS, AML - Medpage Today
Azacitadine Plus Pevonedistat Shows Efficacy in MDS/CMML or LB AML
MDS: an update on pevonedistat plus azacitidine
Pevonedistat with azacitidine for high-risk MDS
Comparing pevonedistat plus azacitidine versus azacitidine alone in patients with higher-risk MD...
The impact of pevonedistat on patient-reported outcomes in the P-2001 study
A Randomized Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine
Higher-risk MDS in 2021: pevonedistat, sabatolimab & APR-246
Azacitidine Plus APR-246 Appears Promising as Treatment of TP53-Mutant MDS and AML
